Retractable Technologies (NYSE:RVP – Get Free Report) and Sight Sciences (NASDAQ:SGHT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.
Risk & Volatility
Retractable Technologies has a beta of 2.16, meaning that its stock price is 116% more volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500.
Institutional & Insider Ownership
10.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 50.7% of Sight Sciences shares are held by institutional investors. 55.0% of Retractable Technologies shares are held by company insiders. Comparatively, 27.1% of Sight Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Earnings and Valuation
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Retractable Technologies||$54.71 million||0.59||$5.08 million||($0.37)||-2.92|
|Sight Sciences||$71.33 million||1.54||-$86.24 million||($1.27)||-1.77|
Retractable Technologies has higher earnings, but lower revenue than Sight Sciences. Retractable Technologies is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.
This is a summary of recent ratings and recommmendations for Retractable Technologies and Sight Sciences, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Sight Sciences has a consensus target price of $4.40, suggesting a potential upside of 95.56%. Given Sight Sciences’ higher possible upside, analysts plainly believe Sight Sciences is more favorable than Retractable Technologies.
This table compares Retractable Technologies and Sight Sciences’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Retractable Technologies beats Sight Sciences on 7 of the 13 factors compared between the two stocks.
About Retractable Technologies
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. The company was incorporated in 1994 and is headquartered in Little Elm, Texas.
About Sight Sciences
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.